Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Dianthus Therapeutics (DNTH) FCF Margin (2022 - 2025)

Dianthus Therapeutics (DNTH) has 4 years of FCF Margin data on record, last reported at 7717.17% in Q3 2025.

  • For Q3 2025, FCF Margin fell 673688.0% year-over-year to 7717.17%; the TTM value through Sep 2025 reached 1372.57%, down 19780.0%, while the annual FY2024 figure was 1255.57%, 5267.0% up from the prior year.
  • FCF Margin reached 7717.17% in Q3 2025 per DNTH's latest filing, up from 12403.11% in the prior quarter.
  • Across five years, FCF Margin topped out at 440.66% in Q4 2024 and bottomed at 12403.11% in Q2 2025.
  • Average FCF Margin over 4 years is 2799.0%, with a median of 1400.79% recorded in 2023.
  • Peak YoY movement for FCF Margin: soared 234432bps in 2024, then plummeted -1162238bps in 2025.
  • A 4-year view of FCF Margin shows it stood at 766.84% in 2022, then plummeted by -263bps to 2784.98% in 2023, then skyrocketed by 84bps to 440.66% in 2024, then tumbled by -1651bps to 7717.17% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 7717.17% in Q3 2025, 12403.11% in Q2 2025, and 2377.82% in Q1 2025.